We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Zika Vaccine Shows Protective Efficacy in Monkeys

News   Dec 06, 2018 | Original story from the University of Hawai'i at Manoa

 
Zika Vaccine Candidate Effective in Preclinical Trials

Zika virus results in neurological complications in babies born from infected mothers. The immunogenicity and protective efficacy of a recombinant subunit vaccine candidate has been demonstrated in mice, and in long-tailed macaques (Macaca fascicularis, also known as the crab-eating macaque). Image credit: Mr. Theklan.

 
 
 

RELATED ARTICLES

Researchers Create Renewable Source of Cancer-fighting T Cells

News

A study by UCLA researchers is the first to demonstrate a technique for coaxing pluripotent stem cells — which can give rise to every cell type in the body and which can be grown indefinitely in the lab — into becoming mature T cells capable of killing tumor cells.

READ MORE

Tuberculosis Tests are Inadequate, Better Options Identified

News

Rapid blood tests used by the NHS are unable to rule out tuberculosis (TB) and should be replaced with a new, more accurate test, a study has found.

READ MORE

Protein Interactions Shed Light on Ebola Virus Replication

News

Researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE